← Back to Companies
Novo Nordisk Pharmaceuticals, Inc.
About
As the U.S. affiliate of Novo Nordisk A/S in Copenhagen, Denmark, Novo Nordisk Pharmaceuticals develops and manufactures biopharmaceuticals and diabetes care products. Novo Nordisk was the first company to create the insulin pen and today is a leader in human and analog insulin distribution. Novo Nordisk is also dedicated to creating pharmaceuticals for those with hemophilia and hormone deficiencies. North American headquarters are located in Princeton, NJ. ** NOTE: As a privately held subsidiary of a publicly traded parent company, annual revenue and employee count are not readily available. Therefore, the revenue and employee figures presented below are those of the parent company. **
(609) 987-5800
Plainsboro, NJ USA
11-50
Primary Address: 800 Scudders Mill RoadPlainsboro, NJ 8536USA
Parent Company:Novo Nordisk Pharmaceuticals, Inc.
Employees (27)
| Name | Title | Phone Number | Social Media | |
|---|---|---|---|---|
| R*** A*** | OmniChannel Marketing - Campaign Planning Manager | (609) 987-**** | | |
| C*** A****** | Executive Director - Insulin & Digital Health Marketing | c**[email protected] | (609) 987-**** | |
| S******* B**** ********** | Senior Category Manager, Marketing Procurement | s**[email protected] | (609) 987-**** | |
| J***** B**** | Director, Marketing - Insulin & Lifecycle Management Team | j**[email protected] | (609) 987-**** | |
| J***** B*** | Senior Director, Commercial Insights & Analytics - Patient Support Programs | j**[email protected] | (609) 987-****(609) 786-**** | |
| B*** B********** | Senior Director, Market Access - National Accounts | b**[email protected] | (609) 987-**** | |
| J** B**** | Brand Director, HCP Strategy Lead - Rybelsus | (609) 987-**** | | |
| K**** C****** | Marketing Coordinator | (609) 987-**** | | |
| L**** D******** | Senior Category Manager | l**[email protected] | (609) 987-**** | |
| B****** F******** | Brand Manager - Rybelsus | b**[email protected] | | |
| R**** G****** | Vice President, Clinical Development & Outcomes Research | | ||
| J*** H********* | Director, Patient Marketing | j**[email protected] | | |
| M******* J****** | Associate Director, Patient Marketing - Biopharmaceuticals | m**[email protected] | | |
| W**** K**** | Associate Director, Health System Execution - West Area | w****[email protected] | | |
| A**** M***** | Senior Director, Commercial Business Unit Communications | a**[email protected] | | |
| A*** M******** | Brand Director - Victoza | a**[email protected] | | |
| C**** M******** | Associate Director, Convention Marketing | | ||
| M****** L******* | Vice President, Hemophilia Marketing | m**[email protected] | | |
| V****** L***** ******* | Brand Director | v**[email protected] | | |
| S**** L**** | District Business Manager | | ||
| K***** M**** | Associate Director, Category Management - Marketing Procurement | | ||
| J***** S****** | Head GLP-1 Injectable Portfolio | | ||
| E******* S**** | Director, Brand Marketing | e*******[email protected] | | |
| J***** S***** | Senior Brand Manager - Ozempic & Victoza | j**[email protected] | | |
| C******** S******** | Senior Director, Patient Marketing - Obesity | | ||
| K**** W******* | Senior Manager, Internal Communications | k**[email protected] | | |
| J******* W****** | Executive Director - Rybesus | |